|3.22|| +0.03 / +0.94%|
GenVec, Inc. is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. It is working with other companies and organizations such as Novartis, Merial, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of a number of significant human and animal health concerns. The company's development programs address therapeutic areas such as hearing loss, balance disorders and cancer; as well as vaccines against infectious diseases, including respiratory syncytial virus, herpes simplex virus, dengue fever and malaria. GenVec was founded in December 1992 and is headquartered in Gaithersburg, MD.
|Douglas J. Swirsky||President, CEO, Secretary & Director|
|James Vincent Lambert||CFO, CAO, Controller & Treasurer|
|Douglas E. Brough||Chief Scientific Officer|
|Bryan T. Butman||Senior Vice President-Development|
|Rena Cohen||Head-Investor Relations|